These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1950094)

  • 1. Immunogenicity of trivalent subunit and split influenza vaccines (1989-90 winter season) in volunteers of different groups of age.
    Zei T; Neri M; Iorio AM
    Vaccine; 1991 Sep; 9(9):613-7. PubMed ID: 1950094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of humoral immune responses to trivalent influenza split vaccine in young, middle-aged and elderly people.
    Glathe H; Bigl S; Grosche A
    Vaccine; 1993; 11(7):702-5. PubMed ID: 8342318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects.
    Squarcione S; Sgricia S; Biasio LR; Perinetti E
    Vaccine; 2003 Mar; 21(11-12):1268-74. PubMed ID: 12559808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Seroconversion after vaccine with trivalent influenza vaccine during the epidemic season 1990/1 in Poland].
    Brydak L; Rudnicka H; Gut W; Magdzik W; Kańtoch M
    Przegl Epidemiol; 1992; 46(3):221-9. PubMed ID: 1296247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization of elderly volunteers with the 1988-89 inactivated whole influenza vaccine: assessment of antibody responses by haemagglutination inhibition and single radial haemolysis tests.
    Iorio AM; Zei T; Neri M; Campitelli L; Castrucci MR; Donatelli I
    Eur J Epidemiol; 1992 Jul; 8(4):491-7. PubMed ID: 1397214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response to trivalent inactivated influenza vaccine in young and elderly subjects.
    Iorio AM; Rivosecchi P; Zei T; Neri M; Merletti L
    Vaccine; 1989 Aug; 7(4):341-4. PubMed ID: 2815969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses.
    van de Witte S; Nauta J; Montomoli E; Weckx J
    Vaccine; 2018 Sep; 36(40):6030-6038. PubMed ID: 29709447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of a single dose of trivalent influenza vaccine including A/Philippines (H3N2): results of a field trial.
    Green MS; Block C; Rannon L
    J Med Virol; 1986 Jun; 19(2):161-6. PubMed ID: 3723117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages.
    Camilloni B; Neri M; Lepri E; Iorio AM
    Vaccine; 2009 Jun; 27(31):4099-103. PubMed ID: 19410623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection.
    Masurel N; Laufer J
    J Hyg (Lond); 1984 Jun; 92(3):263-76. PubMed ID: 6736638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 21-winter seasons retrospective study of antibody response after influenza vaccination in elderly (60-85 years old) and very elderly (>85 years old) institutionalized subjects.
    Nunzi E; Iorio AM; Camilloni B
    Hum Vaccin Immunother; 2017 Nov; 13(11):2659-2668. PubMed ID: 28922621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of seroconversion after vaccination against influenza during the epidemic season 1991-1992 in Poland].
    Brydak L; Rudnicka H
    Przegl Epidemiol; 1993; 47(3):275-83. PubMed ID: 8234846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response of adults to sequential influenza vaccination.
    Powers RD; Hayden FG; Samuelson J; Gwaltney JM
    J Med Virol; 1984; 14(2):169-75. PubMed ID: 6491643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trivalent influenza vaccine in patients on haemodialysis: impaired seroresponse with differences for A-H3N2 and A-H1N1 vaccine components.
    Beyer WE; Versluis DJ; Kramer P; Diderich PP; Weimar W; Masurel N
    Vaccine; 1987 Mar; 5(1):43-8. PubMed ID: 3577356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and safety of a cell culture-derived inactivated trivalent influenza vaccine (NBP607): A randomized, double-blind, multi-center, phase 3 clinical trial.
    Song JY; Cheong HJ; Lee J; Woo HJ; Wie SH; Lee JS; Kim SW; Noh JY; Choi WS; Kim H; Kim KH; Kim WJ
    Vaccine; 2015 Oct; 33(41):5437-5444. PubMed ID: 26314625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological responses in volunteers to inactivated trivalent subunit influenza vaccine: antibody reactivity with epidemic influenza A and B strains and evidence of a rapid immune response.
    Zuckerman MA; Wood J; Chakraverty P; Taylor J; Heath AB; Oxford JS
    J Med Virol; 1991 Feb; 33(2):133-7. PubMed ID: 2051142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial.
    Vesikari T; Kirstein J; Devota Go G; Leav B; Ruzycky ME; Isakov L; de Bruijn M; Oberye J; Heijnen E
    Lancet Respir Med; 2018 May; 6(5):345-356. PubMed ID: 29631857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of influenza vaccines against heterovariant influenza virus strains in adults with chronic diseases.
    Baldo V; Baldovin T; Floreani A; Fragapane E; Trivello R;
    J Clin Immunol; 2007 Sep; 27(5):542-7. PubMed ID: 17514499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.